Manchester Capital Management’s Boston Scientific BSX Stock Holding History

Manchester Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$578K	Buy	9,216 +196	+2%	+$15.7K	0.08%	148
2025 Q4	$860K	Buy	9,020 +659	+8%	+$64.6K	0.12%	111
2025 Q3	$816K	Sell	8,361 -1,175	-12%	-$122K	0.11%	124
2025 Q2	$1.02M	Buy	9,536 +17	+0.2%	+$1.72K	0.13%	120
2025 Q1	$960K	Buy	9,519 +504	+6%	+$50.8K	0.12%	120
2024 Q4	$805K	Hold	9,015	–	–	0.09%	138
2024 Q3	$755K	Buy	9,015 +11	+0.1%	+$867	0.09%	150
2024 Q2	$693K	Buy	9,004 +1,281	+17%	+$93.8K	0.08%	149
2024 Q1	$529K	Buy	7,723 +491	+7%	+$31.6K	0.06%	184
2023 Q4	$418K	Buy	7,232 +148	+2%	+$7.9K	0.06%	195
2023 Q3	$374K	Hold	7,084	–	–	0.06%	194
2023 Q2	$383K	Hold	7,084	–	–	0.05%	199
2023 Q1	$354K	Hold	7,084	–	–	0.05%	224
2022 Q4	$328K	Hold	7,084	–	–	0.05%	196
2022 Q3	$274K	Hold	7,084	–	–	0.05%	185
2022 Q2	$264K	Hold	7,084	–	–	0.05%	192
2022 Q1	$314K	Hold	7,084	–	–	0.05%	208
2021 Q4	$301K	Hold	7,084	–	–	0.04%	222
2021 Q3	$307K	Sell	7,084 -163	-2%	-$7.21K	0.04%	227
2021 Q2	$310K	Buy	7,247 +163	+2%	+$6.86K	0.04%	227
2021 Q1	$274K	Hold	7,084	–	–	0.04%	227
2020 Q4	$255K	Buy	7,084 +127	+2%	+$4.58K	0.04%	219
2020 Q3	$266K	Hold	6,957	–	–	0.04%	202
2020 Q2	$244K	Hold	6,957	–	–	0.03%	220
2020 Q1	$227K	Hold	6,957	–	–	0.04%	210
2019 Q4	$315K	Hold	6,957	–	–	0.03%	209
2019 Q3	$283K	Hold	6,957	–	–	0.03%	208
2019 Q2	$299K	Hold	6,957	–	–	0.04%	204
2019 Q1	$267K	Hold	6,957	–	–	0.03%	207
2018 Q4	$227K	Hold	6,957	–	–	0.03%	203
2018 Q3	$268K	Hold	6,957	–	–	0.04%	193
2018 Q2	$227K	Hold	6,957	–	–	0.03%	206
2018 Q1	$190K	Hold	6,957	–	–	0.03%	209
2017 Q4	$172K	Hold	6,957	–	–	0.03%	213
2017 Q3	$203K	Hold	6,957	–	–	0.03%	180
2017 Q2	$193K	Hold	6,957	–	–	0.03%	199
2017 Q1	$173K	Hold	6,957	–	–	0.03%	211
2016 Q4	$150K	Hold	6,957	–	–	0.02%	216
2016 Q3	$166K	Hold	6,957	–	–	0.03%	213
2016 Q2	$163K	Hold	6,957	–	–	0.02%	220
2016 Q1	$131K	Hold	6,957	–	–	0.02%	248
2015 Q4	$128K	Hold	6,957	–	–	0.02%	266
2015 Q3	$114K	Hold	6,957	–	–	0.02%	273
2015 Q2	$123K	Hold	6,957	–	–	0.02%	267
2015 Q1	$123K	Sell	6,957 -3,078	-31%	-$48.6K	0.02%	252
2014 Q4	$133K	Hold	10,035	–	–	0.02%	472
2014 Q3	$119K	Hold	10,035	–	–	0.02%	520
2014 Q2	$128K	Hold	10,035	–	–	0.02%	501
2014 Q1	$136K	Hold	10,035	–	–	0.02%	451
2013 Q4	$121K	Hold	10,035	–	–	0.02%	450
2013 Q3	$118K	Hold	10,035	–	–	0.02%	437
2013 Q2	$93K	Buy	+10,035	New	+$85.1K	0.02%	465

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Manchester Capital Management's BSX Position: Q1 2026 in Review

Manchester Capital Management increased its Boston Scientific (BSX) stake by 2.2% in Q1 2026, buying an estimated $15.7K and bringing the position to 9,216 shares worth $578K. The position accounts for 0.08% of the portfolio, ranked #148.

Manchester Capital Management first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.02M in Q2 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Manchester Capital Management held 9,216 shares of Boston Scientific worth $578K as of Q1 2026.
Manchester Capital Management bought 196 Boston Scientific shares in Q1 2026, an estimated $15.7K.
Boston Scientific made up 0.08% of Manchester Capital Management's portfolio in Q1 2026, its #148 holding.
Manchester Capital Management first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
Manchester Capital Management's Boston Scientific position peaked at $1.02M in Q2 2025.
1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.